1) Pure red cell aplasia
纯红再障
1.
Objective To investigate the clinical features of pure red cell aplasia (PRCA), and to evaluate the effectiveness of immunosuppressive therapy.
方法 收集从1989年至今四川大学华西医院诊断为纯红再障的住院病人和从2000年至今四川大学华西医院血液科门诊随访的纯红再障病人。
2) pure red cell aplasia
纯红细胞再生障碍
1.
Immunosuppressive therapy for pure red cell aplasia and aplastic anemia;
纯红细胞再生障碍和再生障碍性贫血的免疫抑制治疗
2.
Six out of 20 patients undergoing a major ABO incompatible allogeneic stem cell transplantation(allo HSCT) developed pure red cell aplasia(PRCA), which did not show any effects on granulocyte and platelet engraftment, and incidence of grade Ⅱ-Ⅳ aGVHD.
20例主要ABO血型不合异基因造血干细胞移植 (allo HSCT)患者中 ,6例发生纯红细胞再生障碍(PRCA)。
3) Pure red cell aplasia
纯红细胞再生障碍性贫血
1.
Thymoma associated with pure red cell aplasia: a cases report and review of Chinese literatures;
胸腺瘤合并单纯红细胞再生障碍性贫血1例及文献复习
2.
Clinic analysis of 24 cases with pure red cell aplasia;
24例纯红细胞再生障碍性贫血临床分析
3.
Objective:To investigate the diagnosis, etiology, pathogenesis and therapy of pure red cell aplasia (PRCA).
目的 :探讨纯红细胞再生障碍性贫血的病因、发病机制、诊断和治疗。
4) pure erythroid aplasia
单纯红系再生障碍性贫血
1.
The aim of this study was to investigate the curative effects of amifostine(AMF) combined with recombinant human β-erythropoietin(rhβ-EPO) on patients with pure erythroid aplasia(PEA).
本研究旨在观察氨磷汀(AMF)联合重组人β红系生成素(rhβ-EPO)对单纯红系再生障碍性贫血(PEA)患者的近期疗效及副作用。
5) pure red cell aplasia (PRCA)
单纯红细胞再生障碍性贫血
1.
Objective: to understand the pathogenesis , clinical features, methodes of diagnosis of thymoma associated with pure red cell aplasia (PRCA) and to evaluate the outcome of the therapy.
目的 探讨胸腺瘤合并单纯红细胞再生障碍性贫血的发病机理、临床表现、诊断方法和有效的治疗方法。
补充资料：红障
红障
红障 病证名。指翳膜之色红赤者。《审视瑶函》卷三：“大抵红障凹凸，怕如血积肉堆。”漫掩整黑睛，障碍视力。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条